IP vs LYEL · P/E 43, $26.62B cap vs rev $61.0K
International Paper (IP) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported LYEL revenue for 2024-12-31 was $61.0K. Net income was -$343.0M. Revenue was down 53.1% from 2023-12-31 to 2024-12-31. LYEL currently screens at market cap $143.5M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the IP and LYEL stock pages for the full models.
Not investment advice.